Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001586226-26-000004

Options or other derivatives

  • Director acquired 17,786 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TZIANABOS ARTHUR · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-03 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +17,786 17,786 D
Loading xslF345X06/form4-06052026_080612.xml…